EuroEyes International Eye Clinic Limited
HKEX:1846.HK
4.25 (HKD) • At close November 14, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
---|---|---|---|---|---|---|---|---|
Assets: | ||||||||
Current Assets: | ||||||||
Cash & Cash Equivalents
| 720.216 | 779.567 | 845.636 | 761.894 | 787.087 | 148.355 | 61.452 | 44.009 |
Short Term Investments
| 32.47 | 21.398 | 15.944 | 31.742 | 23.854 | 14.219 | 0 | 0 |
Cash and Short Term Investments
| 720.384 | 779.567 | 861.58 | 761.894 | 787.087 | 148.355 | 61.452 | 44.009 |
Net Receivables
| 6.877 | 24.592 | 0 | 39.79 | 2.495 | 19.091 | 3.065 | 3.347 |
Inventory
| 16.166 | 16.379 | 23.657 | 36.243 | 30.789 | 30.983 | 15.86 | 10.081 |
Other Current Assets
| 42.894 | 15.396 | 32.577 | 59.737 | 9.484 | 34.866 | 93.698 | 11.578 |
Total Current Assets
| 787.882 | 838.308 | 956.836 | 897.73 | 853.708 | 214.217 | 174.074 | 69.015 |
Non-Current Assets: | ||||||||
Property, Plant & Equipment, Net
| 622.226 | 452.169 | 355.636 | 365.41 | 331.647 | 329.466 | 246.089 | 229.262 |
Goodwill
| 271.352 | 186.279 | 7.568 | 7.352 | 6.622 | 6.8 | 7.114 | 6.19 |
Intangible Assets
| 37.3 | 33.422 | 4.539 | 5.101 | 5.305 | 6.209 | 7.293 | 7.047 |
Goodwill and Intangible Assets
| 308.652 | 219.701 | 12.107 | 12.453 | 11.926 | 13.009 | 14.407 | 13.237 |
Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Tax Assets
| 31.525 | 27.505 | 26.438 | 26.402 | 21.707 | 18.986 | 17.594 | 13.164 |
Other Non-Current Assets
| 3.313 | 3.357 | 18.005 | 12.186 | 15.704 | 15.151 | 0.356 | 0.245 |
Total Non-Current Assets
| 965.716 | 702.732 | 412.186 | 416.451 | 380.985 | 376.612 | 278.446 | 255.907 |
Total Assets
| 1,753.598 | 1,541.04 | 1,369.022 | 1,314.181 | 1,234.693 | 590.83 | 452.52 | 324.922 |
Liabilities & Equity: | ||||||||
Current Liabilities: | ||||||||
Account Payables
| 22.592 | 20.043 | 21.537 | 21.053 | 24.979 | 16.703 | 23.509 | 19.403 |
Short Term Debt
| 70.742 | 47.765 | 45.415 | 51.307 | 45.849 | 43.974 | 71.716 | 57.687 |
Tax Payables
| 10.693 | 43.975 | 44.647 | 19.28 | 14.265 | 41.546 | 31.195 | 16.1 |
Deferred Revenue
| 15.775 | 11.8 | 8.115 | 7.952 | 6.988 | 41.546 | 32.329 | 16.32 |
Other Current Liabilities
| 50.664 | 40.128 | 22.765 | 26.945 | 101.395 | 48.795 | 21.605 | 16.198 |
Total Current Liabilities
| 170.466 | 163.711 | 142.479 | 126.537 | 186.488 | 151.078 | 147.809 | 109.387 |
Non-Current Liabilities: | ||||||||
Long Term Debt
| 313.52 | 242.646 | 176.061 | 188.24 | 188.063 | 190.317 | 97.971 | 109.534 |
Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Tax Liabilities Non-Current
| 17.891 | 13.57 | 8.963 | 8.667 | 8.105 | 9.3 | 9.533 | 8.482 |
Other Non-Current Liabilities
| 86.213 | 78.02 | 1.042 | 1.125 | 9.13 | 1.057 | 10.796 | 0.962 |
Total Non-Current Liabilities
| 417.624 | 334.236 | 186.066 | 198.032 | 197.193 | 200.751 | 108.61 | 118.978 |
Total Liabilities
| 588.09 | 497.947 | 328.545 | 324.569 | 383.681 | 351.83 | 256.419 | 228.365 |
Equity: | ||||||||
Preferred Stock
| 10.505 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Common Stock
| 26.138 | 26.138 | 25.826 | 25.826 | 25.964 | 0.269 | 0.309 | 0.269 |
Retained Earnings
| 397.379 | 304.488 | 248.113 | 124.744 | 54.659 | 125.947 | 95.834 | 12.372 |
Accumulated Other Comprehensive Income/Loss
| 63.393 | 35.155 | 116.655 | 181.584 | 97.25 | -218.375 | -173.324 | -109.346 |
Other Total Stockholders Equity
| 637.361 | 751.637 | 718.434 | 717.554 | 717.032 | 104.646 | 94.273 | 78.383 |
Total Shareholders Equity
| 1,134.776 | 1,014.266 | 1,005.552 | 953.292 | 806.735 | 226.573 | 187.403 | 89.07 |
Total Equity
| 1,165.508 | 1,043.093 | 1,040.477 | 989.612 | 851.012 | 239 | 196.101 | 96.558 |
Total Liabilities & Shareholders Equity
| 1,753.598 | 1,541.04 | 1,369.022 | 1,314.181 | 1,234.693 | 590.83 | 452.52 | 324.922 |